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GUIDE FOR AUTHORS
Increasingly, health care decision makers and policy makers are seeking 
outcomes research information (comparative treatment effectiveness, 
economic costs and beneﬁ ts, and patient-reported outcomes) that can 
guide them in health care resource allocation, and in evaluating alternative 
treatments and health services interventions. Value in Health contains 
original research articles in the areas of economic evaluation (including 
drugs and other medical technologies), outcomes research (“real world” 
treatment effectiveness, and patient-reported outcomes research), and 
conceptual, methodological, and health policy articles. All published articles 
must be conducted in a rigorous manner and must reﬂ ect valid and reliable 
theory and methods. Empirical analyses and conceptual models must 
reﬂ ect ethical research practices and provide valuable information for health 
care decision making as well as the research community. As the ofﬁ cial 
journal of the International Society for Pharmacoeconomics and Outcomes 
Research (ISPOR), Value in Health provides a forum for researchers, health 
care decision-makers, and policy makers to translate pharmacoeconomics 
and outcomes research into health care decisions. Given that the ultimate 
purpose of health care is to increase the overall health-related well being 
of individuals and society as a whole in an efﬁ cient manner, the content of 
Value in Health focuses on health care value. 
Value in Health welcomes papers that make substantial contributions by 
providing new evidence or ideas that extend the current knowledge base. 
As such, manuscripts should describe the unique contribution of the article 
and place the current paper in context with prior publications. Value in Health 
does not consider papers reporting data series or data sets that do not 
include appropriate statistical analyses. The journal uses the peer review 
process to assure rigorous and transparent use of statistical methods. 
Value in Health also requires that papers reporting modeling results include 
sensitivity analysis of key and inﬂ uential model parameters.
Value in Health publishes all papers in English and authors are 
responsible for assuring that the paper reﬂ ects good grammar prior to 
submission. Authors for whom English is a second language may choose 
to have their manuscript professionally edited before submission. Authors 
wishing to pursue a professional English-language editing service should 
make contact and arrange payment with the editing service of their 
choice. For more details regarding recommended services, please refer 
to http://support.elsevier.com/ 
I. ETHICS IN PUBLISHING
For information on Ethics in Publishing and Ethical guidelines for journal
publication see http://www.elsevier.com/publishingethics and http:// 
www.elsevier.com/ethicalguidelines.
II. CONFLICT OF INTEREST
All authors must disclose any ﬁ nancial and personal relationships with 
other people or organizations that could inappropriately inﬂ uence 
(bias) their work. Examples of potential conﬂ icts of interest include 
employment, consultancies, stock ownership, honoraria, paid expert 
testimony, patent applications/registrations, and grants or other funding. 
See also http://www.elsevier.com/conﬂ ictsoﬁ nterest.
III. SUBMISSION DECLARATION
Submission of an article implies that the work described has not been 
published previously (except in the form of an abstract or as part of a 
published lecture or academic thesis), that it is not under consideration 
for publication elsewhere, that its publication is approved by all authors 
and tacitly or explicitly by the responsible authorities where the work 
was carried out, and that, if accepted, it will not be published elsewhere 
including electronically in the same form, in English or in any other lan-
guage, without the written consent of the copyright-holder.
IV. RETAINED AUTHOR RIGHTS
As an author you (or your employer or institution) retain certain rights; 
for details you are referred to: http://www.elsevier.com/authorsrights.
V. FUNDING BODY AGREEMENTS AND POLICIES
Elsevier has established agreements and developed policies to allow au-
thors whose articles appear in journals published by Elsevier, to comply 
with potential manuscript archiving requirements as speciﬁ ed as condi-
tions of their grant awards. To learn more about existing agreements and 
policies please visit http://www.elsevier.com/fundingbodies.
VI. MANUSCRIPT SUBMISSION AND  SPECIFICATIONS
To submit a manuscript to Value in Health, please go to: http://
mc.manuscriptcentral.com/vih. For assistance, authors may contact 
the Value in Health editorial ofﬁ ce at: viheditor@ispor.org.
If submissions are larger than 500 KB, they should be compressed 
using PKZIP or WINZIP.
Authors will be required to assign copyright of their papers. Copyright 
assignment is a condition of publication and papers will not be passed 
to the publisher for production unless copyright has been  assigned. An 
 appropriate copyright assignment form can be found at the following 
 address: http://www.ispor.org/publications/value/Value-In-Health-Copyright-
Transfer-Form_2012.pdf. A faxed copy of this completed and signed form is 
acceptable; fax to 609-586-4982 or email to: viheditor@ispor.org. 
If excerpts from other copyrighted works are included, the author(s) 
must obtain written permission from the copyright owners and credit the 
source(s) in the article. Elsevier has preprinted forms for use by authors in 
these cases: please consult http://www.elsevier.com/permissions.
Each Submission should contain separate documents as follows:
i. COVER LETTER. The cover letter should include: 1) title of the 
manuscript; 2) name of the document ﬁ le(s) containing the manuscript 
and the software (and version) used; 3) name and all contact 
information for the corresponding author and a statement as to 
whether the data, models, or methodology used in the research are 
proprietary; 4) names of all sponsors of the research and a statement 
of all direct or indirect ﬁ nancial relationships the authors have with 
the sponsors; and 5) if applicable, a statement that the publication 
of study results was not contingent on the sponsor’s approval or 
censorship of the manuscript.
ii. TITLE PAGE. The title page should contain the following: 1) title; 
2) full names (ﬁ rst and surname) of all authors including academic 
degrees and afﬁ liation(s); 3) name, mailing and email addresses, 
telephone and fax numbers of corresponding author (with whom all 
correspondence will take place unless other arrangements are made); 
4) all sources of ﬁ nancial or other support for the manuscript (if no 
funding was received, this should be noted on the title page); 5) at 
least four key words for indexing purposes; and 6) a running title of 
not more than 45 characters including spaces.
iii. MANUSCRIPTS. Manuscripts must be written in English, typed in 
Microsoft Word (2003 or later; .doc or .docx ﬁ le formats). Manuscripts 
should be in 8.5x11-inch page format, double-spaced with 1-inch 
margins on all sides and size 10 font (Arial or Times New Roman fonts 
are preferred). Minimal formatting should be used, i.e., no justiﬁ cation, 
italics, bold, indenting, etc. There should be no hard returns at the 
end of lines. Double-spacing after each element is requested (e.g., 
headings, titles, paragraphs, legends). The ‘Uniform Requirements for 
Manuscripts Submitted to Biomedical Journals’ should be consulted 
for speciﬁ c style issues not addressed here (www.acponline.org, Ann 
Intern Med 1997;126:36-47).
a. KEY POINTS. Value in Health is keen to publish papers that add 
to the literature in a substantive way to inform healthcare-related 
decision making. Therefore, during the submission process, authors 
are asked to identify several ‘Key Points’. The Key Points should not 
summarize the article, but rather should highlight the novel insights 
related to value in health care delivery that the paper provides. 
  i. What is already known about the topic? 
  ii. What does the paper add to existing knowledge? 
 iii.  (optional) What insights does the paper provide for informing 
health care-related decision making? 
b. ABSTRACT. An abstract of 250 words or less is required, 
 summarizing the work reported in the manuscript. Original research 
manuscripts should use a structured format for the abstract, i.e., 
Objectives, Methods, Results, and Conclusions.
c. TEXT. The body of the manuscript should be divided into 
sections that facilitate reading and comprehension of the material. 
This should normally include sections with the major headings: 
Introduction, Methods, Results, Conclusions, Acknowledgments 
(if needed), and References. There should be no footnotes. Figures 
(inclusive of ﬁ gure legends) and Tables must be submitted each as 
separate documents.
d. REFERENCES. References should be listed in a separate 
section and numbered consecutively with Arabic numerals in the 
order in which they are cited in the text. Referencing software, 
superscripts, or any other electronic format should not be used 
when referencing, neither in the text nor the reference list. Citing 
unpublished or non-peer-reviewed work such as abstracts and 
presented papers is discouraged. Personal communications may 
be indicated in the text as long as written acknowledgment from 
the authors of the communications accompanies the manuscript. 
Reference style should follow that of Index Medicus. 
Spell out single-word journals and abbreviate all others according to 
the style of Index Medicus. If there are more than four authors, use 
only the names of the ﬁ rst three, followed by et al.
The four most common types of references are illustrated 
below for example.
Journal article: Surname and initials of author(s), title of article, 
name of journal, year, volume number, ﬁ rst and last page. 
Arocho R, McMillan CA. Discriminant and criterion evaluation of the 
U.S.-Spanish version of the SF-36 Health Survey in a Cuban-American 
population with benign hyperplasia. Med Care 1998;36:766-72.
Book: Surname and initials of author(s)/editor(s), title and subtitle, 
volume, edition (other than ﬁ rst), city, publisher, year. 
Johnston J. Econometric Methods (3rd ed.). New York: McGraw-Hill, 
1984.
Chapter in Book: Surname and initials of author(s), title of chapter, 
author(s)/editor(s) of book, title of book, volume, edition (other than 
ﬁ rst), city, publisher, year. 
Luce BR, Manning WG, Siegel JE, et al. Estimating costs in cost-
effectiveness analysis. In: Gold MR, Siegel JE, Russell LB, et al., 
eds., Cost-effectiveness in Health and Medicine. New York: Oxford 
University Press, 1996.
Website: WWW Document. Available from: http://www . . . 
[Accessed Month Day, year]. 
International Society for Pharmacoeconomics and Outcomes Re-
search (ISPOR). ISPOR Good Outcomes Research Practices Index. 
Available from: http://www.ispor.org/workpaper/practices_index.
asp. [Accessed January 1, 2011]. 
iv. TABLES. Tables should be clearly labeled, neatly typed, and easy 
to understand without reference to the text. Each should be double-
spaced and presented on a separate page. Statistical estimates 
should indicate parameter estimates and, as appropriate, t ratios or 
standard error, statistical signiﬁ cance, sample size, and other relevant 
information. All abbreviations must be explained below each table. 
Each table should be numbered and have a self-explanatory title.
v. FIGURES. Figures should each be submitted as a separate image 
ﬁ le, not embedded in the manuscript document or in a slide presenta-
tion. Cite ﬁ gures consecutively, as they appear in the text, with Arabic 
numbers (Figure 1, Figure 2, Figure 3A, etc.). If, together with your 
accepted article, you submit usable color ﬁ gures then the Journal will 
ensure, at no additional charge, that these ﬁ gures will appear in color 
on the Web (e.g., ScienceDirect and other sites) regardless of whether 
or not these illustrations are reproduced in color in the printed version. 
There will be a charge for color reproduction in print; you will receive 
information regarding the costs from Elsevier after receipt of your ac-
cepted article. Please indicate your preference for color in print or on 
the Web only. Each ﬁ gure must be assigned a brief title (as few words 
as possible, and reserving abbreviations for the legend) as well as 
a legend. The corresponding legend should be typed double-spaced 
on a separate page. All symbols, arrows, and abbreviations must be 
explained in the legend. Please submit ﬁ les with a resolution of at least 
300 DPI. Line artwork should contain a resolution of least 1000 DPI. 
Elsevier recommends submitting ﬁ gures in the following formats: TIFF, 
JPG, EPS, and PDF. Please be sure to delete any identifying patient 
information such as name, social security number, etc. Photographs 
in which a person’s face is recognizable must be accompanied by a 
letter of release from that person explicitly granting permission for 
publication in the Journal. For any previously published material, writ-
ten permission for both print and electronic reprint rights must be 
obtained from the copyright holder. For further explanation and exam-
ples of artwork preparation, see Elsevier’s Author Artwork Instructions 
at www.elsevier.com/artwork.
vi. SUPPLEMENTARY MATERIAL OR SUPPLEMENTARY DATA. 
You may submit appendixes that describe either methods or results in 
more detail if these are needed for clarity of understanding by either 
peer reviewers or readers. If appropriate, materials suitable for Web 
publication but not print publication (e.g., audio or video ﬁ les, see 
below) can also be submitted. If you do so, indicate the particular 
reasons for the appendix and whether you are submitting it for 
possible Web publication or simply for peer review purposes. Value in 
Health accepts audio and video ﬁ les as ancillaries to the main article. 
Audio ﬁ les should be in .mp3 format; the recommended upper limit 
for the size of a single ﬁ le is 10 Mb. Video ﬁ les should be submitted in 
.mpg or .mp4 format, the recommended upper limit for the size of a 
single ﬁ le is 10Mb. Any alternative format supplied may be subject to 
conversion (if technically possible) prior to online publication.
vii. SURVEY INSTRUMENT. For papers analyzing preferences, Value 
in Health requires the submission of a copy of the survey instrument 
(translated into English in case of different original language) used to 
generate the preference data. This is to help in the review process 
and the survey instrument need not appear in a ﬁ nal publication. If 
the authors wish the questionnaire to be published with the paper, it 
should be submitted through ScholarOne Manuscripts as part of the 
paper. If they do not wish it to be published, it should be submitted 
through ScholarOne Manuscripts as Supporting Information and then 
will be sent to the reviewers as a reviewer’s appendix.
VII. DATA, MODELS, AND METHODOLOGY
All authors must agree to make their data available at the Editor’s request 
for examination and re-analysis by referees or other persons designated 
by the Editor. All models and methodologies must be presented in 
sufﬁ cient detail to be fully comprehensible to readers. 
VIII. AUTHOR ANONYMITY
From September 15, 2003, it is the policy of Value in Health that peer 
review of submitted manuscripts is double blinded, i.e., the reviewers 
do not know the names of the authors of manuscripts and the authors 
do not know the names of the reviewers. Blinded reviews are common 
practice at many important scientiﬁ c and medical journals. 
IX. THE REVIEW PROCESS
All manuscripts deemed appropriate for Value in Health after initial 
screening will be reviewed by at least two peer reviewers. The objective 
of the journal is to complete peer review and reach editorial decision 
within ten to twelve weeks of submission, at which time the corresponding 
author will receive written notiﬁ cation, including anonymous reviewer 
commentary.
X. AUTHOR TRACKING SERVICES
Authors may track accepted articles at http://www.elsevier.com/trackarticle 
and set up e-mail alerts to inform them when an article’s status has changed. 
Contact details for questions arising after acceptance of an article, especially 
those relating to proofs, will be provided by the publisher.
XI. PROOFS
Proofs will be sent electronically to the Authors to be carefully checked 
for printer’s errors. Substantive changes or additions to the edited 
manuscript cannot be allowed at this stage. Corrected proofs 
should be returned to the publisher within 2 days of receipt. 
XII. OFFPRINTS
The corresponding author, at no cost, will be provided with a PDF ﬁ le of 
the article via e-mail. For an extra charge, paper offprints can be ordered 
via the offprint order form which is sent once the article is accepted 
for publication. The PDF ﬁ le is a watermarked version of the published 
article and includes a cover sheet with the journal cover image and a 
disclaimer outlining the terms and conditions of use.
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